Skip to main content
. Author manuscript; available in PMC: 2013 Oct 9.
Published in final edited form as: J Pathol. 2011 Jun 27;225(2):212–221. doi: 10.1002/path.2929

Table 1.

Outline of clinical-pathological characteristics of implanted RCC cases.

Case
n.
Age of
patient
Sex Diagnosis TNM* Fuhrman
Nuclear Grade
1 48 M cRCC T3b-c NX M1 2
2 61 M cRCC T1 N0 MX 2
3 61 F cRCC T3b NX MX 4
4 79 F cRCC T3 N0 MX 3
5 63 M cRCC T2 N0 MX 2
6 63 M cRCC T3b NX M1 3
7 60 M cRCC T2 N0 MX 2
8 49 M cRCC T1b NX MX 2
9 74 F cRCC T1b NX MX 3
10 50 M cRCC T2 N0 MX 3
11 56 M pRCC T3a N2 MX 3
12 76 F cRCC T3b NX MX 3
13 57 M cRCC T1b NX MX 3
14 53 F Oncocytoma T1 NX MX -
15 74 M cRCC T1b NX MX 2
16 18 F pRCC T3 N2 MX 3
17 48 M cRCC T3a N0 MX 3
18 54 F cRCC T2 N0 MX 3
19 83 M cRCC T3b NX MX 4
20 42 M cRCC T2 N0 MX 2
*

TNM (AJCC Classification 6th edition).